SWISS REJU Wins Highly Coveted “HK01 Good Living Award”, Applauded as Top Beauty Brand in Hong Kong
HONG KONG, July 8, 2024 /PRNewswire/ -- SWISS REJU announced today that it was recognized as the Winner at the prestigious "HK01 Good Living Award - Beauty and Medical Aesthetic Category", upon conclusion of extensive expert evaluation and public voting. The latest honor follows SWISS REJU's recent recognition from Cosmopolitan and JESSICA beauty awards. The luxury beauty clinic's innovative...
Olverembatinib Approved for Commercialization in Macau China
ROCKVILLE, Md. and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies for hematological malignancies, announced today that its novel BCR-ABL1 tyrosine kinase inhibitor (TKI), olverembatinib, has been approved by the Pharmaceutical Administration Bureau (ISAF) of the Macau...
Innovent Launches Environmental, Social and Governance (ESG) Website to Advance Sustainability and Corporate Responsibility
SAN FRANCISCO and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Environmental, Social and Governance (ESG) criteria are key indicators of a company's long-term sustainability. Innovent Biologics has been actively addressing the United Nations' Sustainable Development Goals (SDGs) and recently launched its official ESG website, underscoring the company's firm commitment to sustainable development, corporate responsibility and ethical business practices. The platform...
ESHRE 40th Annual Meeting: Air pollution linked to a decrease in IVF birth rate success, new study shows
AMSTERDAM, July 8, 2024 /PRNewswire/ -- A pioneering study, presented today at the ESHRE 40th Annual Meeting in Amsterdam, has revealed that exposure to fine particulate matter (PM) prior to the retrieval of oocytes during in vitro fertilisation (IVF) can reduce the odds of achieving a live birth by almost 40%. The study analysed PM10 exposure in the two weeks...
Hainan Free Trade Port deepens cooperation with Switzerland
HAIKOU, China, July 7, 2024 /PRNewswire/ -- A report from Hainan International Media Center (HIMC): On July 4, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich, Switzerland. From July 4-6, a delegation from China's southern Hainan Province held Hainan Free Trade Port (FTP) related promotion and...
XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country
- Following its initial approval for the treatment of relapsed/refractory multiple myeloma (R/R MM), XPOVIO® has now received approval as a monotherapy for the treatment of adult patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) marking the second approved indication of XPOVIO® in China.- Results from the registrational SEARCH study in...
Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC)
CHENGDU, China, July 5, 2024 /PRNewswire/ -- Hinova Pharmaceuticals Inc. (688302.SH), a leading biopharmaceutical company dedicated to developing innovative cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for HP518, an investigational drug for the treatment of Androgen-receptor positive (AR+) triple-negative breast cancer (TNBC). This designation is intended to expedite...
KORE Helps mCare Digital Launch the Next Generation of Personal Emergency Technology
mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/ -- KORE, a global leader in Internet of Things ("IoT") Solutions and pioneering IoT hyperscaler, and provider of IoT Connectivity, Solutions and Analytics, and mCare Digital, a leader in assistive technology, is proud to announce the launch of...
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders’ Requisition
GAITHERSBURG, Md., July 5, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the Company received a shareholders' requisition dated June...
IASO Bio and Innovent Enhance Strategic Collaboration in Cell Therapy
SHANGHAI and NANJING, China and SAN JOSE, Calif., July 5, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody products, and Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology,...
